In the November/December 2015 issue of PharmaVOICE, Jeff Aroy comments on how the application of sensors, connectivity, and continuous monitoring can revolutionize drug development in some areas. To read the article, click here.
Evaluating Medicare Stars for cardiovascular disease patients
Considering that cardiovascular disease (CVD) remains the leading cause of death in the United States, particularly affecting the growing population of...